Worldwide distributor of NSN parts and consumables located in the USA.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Diagnostic or lab reagents on a backing, prepared diag/lab reagents whether or not on a backing, not of heading 3002 or 3006; certified ref materials
Composite diagnostic or laboratory reagents, n.E.S.
Chemicals-other
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Questions & Answers: |
|
What are the historical prices recorded for this stock number? | |
No pre-dated pricing for this NSN could be found. | |
Does NSN 6810-00-240-8471 have a shelf life? | |
No. There is no shelf life applicable for this NSN. | |
What NATO entities are users of this NSN? | |
No recorded entities for this stock number. | |
What is the NIIN of NSN 6810-00-240-8471? | |
002408471 or 00-240-8471 | |
Does NSN 6810-00-240-8471 require demilitarization? | |
Yes - ITAR Controlled | |
What is the most recent solicitation for NSN 6810-00-240-8471? | |
No solicitations for this NSN. | |
When was this national stock number assigned to the federal catalog? | |
Nov 07, 1969 |
Ld50 lc50 mixture: none specified by manufacturer.
routes of entry: inhalation: yes skin: yes ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: (acute) inhal: dust/fume may cause
coughing, fever, hdch & naus. Skin: may cause irrit w/redness &
pain. Eye: may cause redness, pain, tearing & irrit. Ingest: may
cause sev abdominal pain, fever, naus, hyperactivity, convuls,
coma & kidney dmg. (chronic) efts may incl bronch, pneum, hdch,
sleep disturb, (efts of overexp)
explanation of carcinogenicity: not relevant.
effects of overexposure: hlth haz: anorexia, liver & kidney dmg & cns
depress. Skin: rptd/prlngd cont may cause derm. Eye: rptd/prlngd
cont may cause conjunct. Ingest: may be anorexia, headaches,
vertigo, nervousness, behavio ral disorders, bouts of excitability,
tremors, numbness of extremities, liver/kidney damage and cns
depression.
medical cond aggravated by exposure: none specified by manufacturer.
First aid: inhal: remove to fresh air immed.If brthg has stopped,
perform artf resp. Keep person warm/at rest. Treat symp &
supportively. Get med attn immed. Skin: remove contam clthg & shoes
immed. Wash affecte d area w/soap/mild detergent & lrg amtsof h*2o
until no evidence of chem remains (approx 15-20 min). Get med attn
immed. Eye: wash immed w/lrg amts of h*2o/normal saline for at
least 15 min, (supdat)
Boiling pt: b.P. Text: ing 14
melt/freeze pt: m.P/f.P text: 995f,535c
spec gravity: 5.026
solubility in water: insoluble
appearance and odor: odorless black or brown-black powder or steel-gray
lumps.
Stability indicator/materials to avoid: yes
aluminum, chlorates, hcl, and sulfides. For more exacting info contact
nehc .
stability condition to avoid: none specified by manufacturer.
hazardous decomposition products: decomposes @ 535c to manganese
sesquioxide and o*2.
Waste disposal methods: observe all federal, state and local regulations
when disposing of substance. For assistance, contact district
director of environmental protection agency.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: manganese dioxide
cas: 1313-13-9
rtecs #: op0350000
fraction by wt: >99%
osha pel: 5 mg/m3
acgih tlv: 5 mg/m3
ingred name: supp data: manganese pois: calcium is eft in removing
manganese,but has no perm eft of symp patients in late (ing 3)
rtecs #: 9999999zz
ingred name: ing 2: stages of manganism. Admin of calcium disodium
edetate is recom. Edetate is avail as 5 ml ampules of 20% (ing 4)
rtecs #: 9999999zz
ingred name: ing 3: soln. Give 15-20 mg/kg (0.08-0.125 ml of 20% soln per
kg body weight) in 250-500 ml of 5% dextrose iv over (ing 5)
rtecs #: 9999999zz
ingred name: ing 4: 1-2 hr period twice daily.Max dose should not exceed
50 mg/kg/day. Drug should be given in 5-day courses (ing 6)
rtecs #: 9999999zz
ingred name: ing 5: w/rest period of at least 2 days between courses.
after first course, subsequent courses should not exceed (ing 7)
rtecs #: 9999999zz
ingred name: ing 6: 50 mg/kg/day. Daily urinalysis should be done during
treatment period. Dosage should be reduced if any (ing 8)
rtecs #: 9999999zz
ingred name: ing 7: unusual urinary findings appear. Iv admin is
contraindicated in presence of elevated cerebrospinal fluid (ing 9)
rtecs #: 9999999zz
ingred name: ing 8: press. For intramuscular admin, give 20% soln (200
mg/ml),12.5 mg/kg body weight every 4-6 hrs.Dilute each(ing 10)
rtecs #: 9999999zz
ingred name: ing 9: dose w/an equal vol of 1% procaine. Dose limitation
is same as that given above antidote should be admin (ing 11)
rtecs #: 9999999zz
ingred name: ing 10: by qualified medical personnel.
rtecs #: 9999999zz
ingred name: spill proc: absorb matl & place into cntnrs for later disp.
for lrgr spills, dike far ahead of spill for later (ing 13)
rtecs #: 9999999zz
ingred name: ing 12: disposal. Keep unnecessary people away. Isolate
hazard area and deny entry.
rtecs #: 9999999zz
ingred name: mp: 995f,535c decomposes.
rtecs #: 9999999zz
Ld50 lc50 mixture: product's ld50 (oral rat) was not stated
routes of entry: inhalation: yes skin: no ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: eye: irritation. Skin: irritation.
inhalation: irritation of upper respiratory tract, excessive
inhalation may cause nauses, weakness, chills, loss of appetite,
manganism. Ingestion: cns depression.
explanation of carcinogenicity: none identified.
effects of overexposure: eye: irritation. Skin: irritation.
inhalation: irritation of upper respiratory tract, nausea, weakness,
chills, loss of appetite, manganism. Ingestion: cns depression.
medical cond aggravated by exposure: none identified.
First aid: if any irritation persists or severe, get medical attention.
eye: flush w/water for 15 min. Skin: wash w/soap & water for 15 min.
inhaled: remove from exposure. Aid or restore breathing as needed.
ingest ed: immediately give large amounts of water & get immediate
medical attention. Nothing by mouth if unconscious.
Hcc: n1
nrc/state lic num: none
boiling pt: b.P. Text: n/a.
melt/freeze pt: m.P/f.P text: 995f,535c
vapor pres: n/a.
vapor density: n/a.
spec gravity: 5.02
ph: n/a.
evaporation rate & reference: n/a.
solubility in water: negligible (
appearance and odor: black crystalline powder. Odorless.
percent volatiles by volume: n/a.
Stability indicator/materials to avoid: yes
strong oxidizing agents, strong acids, strong reducing agents,nitrates,
combust matls, hydrogen peroxide,(supp data)
stability condition to avoid: heat, flame, other sources of ignition.
hazardous decomposition products: none identified.
conditions to avoid polymerization: will not occur.
Waste disposal methods: dispose i/a/w all applicable federal, state and
local environmental regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: manganese dioxide
cas: 1313-13-9
rtecs #: op0350000
fraction by wt: 90-100%
osha pel: 5 mg mn/m3 ceiling
acgih tlv: 5 mg mn/m3